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Langmuir monolayerInvestigating the role of proteoglycans associated to cell membranes is fundamental to comprehend bio-
chemical process that occurs at the level of membrane surfaces. In this paper, we exploit syndecan-4, a
heparan sulfate proteoglycan obtained from cell cultures, in lipid Langmuir monolayers at the air–water in-
terface. The monolayer served as a model for half a membrane, and the molecular interactions involved
could be evaluated with tensiometry and vibrational spectroscopy techniques. Polarization–modulation in-
frared reﬂection–absorption spectroscopy (PM-IRRAS) employed in a constant surface pressure regime
showed that the main chemical groups for syndecan-4 were present at the air–water interface. Subsequent
monolayer decompression and compression showed surface pressure-area isotherms with a large expansion
for the lipid monolayers interacting with the cell culture reported to over-express syndecan-4, which was
also an indication that the proteoglycan was inserted in the lipid monolayer. The introduction of biological
molecules with afﬁnity for syndecam-4, such as growth factors, which present a key role in biochemical pro-
cess of cell signaling, changed the surface properties of the hybrid ﬁlm, leading to a model, by which the
growth factor binds to the sulfate groups present in the heparan sulfate chains. The polypeptide moiety of
syndecan-4 responds to this interaction changing its conformation, which leads to lipid ﬁlm relaxation and
further monolayer condensation.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Syndecans, heparan sulfate proteoglycans (HSPGs), are abundant
molecules associated with the cell surface and extracellular matrix
and consist of a protein core to which heparan sulfate chains are co-
valently attached. Invertebrates and primitive chordates possess a
single syndecan gene while mammals have four syndecan genes
that are divided into two subfamilies consisting of syndecan-1 and
-3, and -2 and -4, respectively [1–4]. Syndecans are type I membrane
glycoproteins, having three major domains, named ectodomain,
transmembrane and cytoplasmic. The amino-terminal sequence of
the core protein is followed by an ectodomain containing Ser–Gly
consensus sequences for the glycosaminoglycan attachment, a single
highly conserved transmembrane domain, and a short highly con-
served cytoplasmic domain. All syndecan proteins carry heparaninfrared reﬂection–absorption
GF, epidermal growth factor;
fected with EJ-ras oncogene;
the expression of RNA interfer-
line
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evier OA license.sulfate chains, and some core proteins can be additionally substituted
with chondroitin sulfate chains [5–9].
Syndecan core proteins range in size from20 to 45 kDa and form sta-
ble dimers as a result of interactions within their transmembrane do-
mains. Central to this is a highly conserved GXXXG motif, which is
common to syndecan transmembrane domains from all species
[10–12]. The transmembrane domains are relatively stable evolutiona-
rily, since only a few amino acids differ among the vertebrate sequences.
These domains contain regions for interactions with other membrane
proteins and for localization to distinct membrane compartments [8].
The cytoplasmic domains contain two invariant regions, a mem-
brane proximal common region (C1) containing a serine and a tyro-
sine and a C-terminal common region (C2), separated by a region
(V) of variable length and composition. The C2 region shows an
EFYA sequence at the C-terminus that can bind to the PDZ domain
present in speciﬁc proteins. PDZ domains, named for PSD-95, Discs-
large, and Zonula occludens-1 proteins, bind speciﬁc C-terminal se-
quences and organize and assemble protein complexes on the inner
surface of the plasma membrane and are thought to link membrane
components to the underlying actin-containing cytoskeleton. The
variable (V) region is distinct for each of the 4 family members, but
its syndecan speciﬁc identity is conserved across species [3]. The
function of this domain is largely unknown except for syndecan-4,
where it is responsible for the assembly of syndecan-4 tetramers
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tein kinase C-α (PKC-α) in focal adhesions [8,13,14]. Syndecan-4 cy-
toplasmic domain is amenable to NMR spectroscopy, and forms a
stable dimer of unusual characteristics. It forms a twisted clamp,
and some of the key residues that stabilize the structure are at either
end of the V region [9,15].
In this sense, it is interesting to investigate the role of syndecan-4 in
simpliﬁedmodels of cell membranes in order to accessmolecular inter-
actions. An interesting approach to artiﬁcially construct cell membrane
surfaces is employing the Langmuir technique, which consists of
spreading insoluble amphiphiles on the air–water interface allowing
for the formation of a monomolecular ﬁlm named Langmuirmonolayer
[16]. This ﬁlm can contain its composition and also its surface density
experimentally controlled. Once formed, techniques involving surface
chemistry, such as surface tensiometry, surface potential, microscopy
and light absorption spectroscopy, may be employed to investigate
the physical chemical parameters involved. Also, hybrid monolayers
can be constructed either by spreading mixed insoluble amphiphiles
or by injecting soluble materials into the aqueous subphase, and allow-
ing for the adsorption of these materials (such as proteins, drugs, and
nucleic acids) from solution to the previously formed monolayer.
Hence hybrid protein–lipid monolayers are useful to mimic half a
membrane as defended in the 1990s [17], this technique has been
also used to investigate interactions involved in molecular recogniz-
ing events [18–21], to construct hybrid ﬁlms of enzymes for biosen-
sing [22–24], and to investigate natural polysaccharide ﬁbers [25].
Also has this technique been shown as a potent tool for studying
the interfacial properties of antimicrobial and membrane-lytic pep-
tides and their interactions with lipid membranes [26–28]. Despite
being able to mimic half a membrane, and being therefore particular-
ly useful to investigate interactions with peripheral proteins, also
monolayers at the air–water interface have been employed to study
interactions of transmembrane proteins with cells [29].
Thus Langmuir monolayers are particularly adequate to investi-
gate interactions of syndecan-4 with lipids at biointerfaces, since we
are leading with a class of molecules associated with cell surfaces
and extracellular matrices. To the best of our knowledge, syndecan-
4 has never been investigated in Langmuir monolayers, although
some studies have reported the interaction of syndecans in other
cell models, such as liposomes [30,31]. Also, other proteoglycans
interacting with lipid Langmuir monolayers have been investigated,
such as arabinogalactan [32], sulfated saccharides interacting with
cardiotoxins [33] or lipids [34], and sugar-binding proteins, such as
lectins [35].
This present work aims to investigate the incorporation of
syndecan-4 in lipid monolayer acting as a cell membrane model. As
we have employed lipid monolayers, which are systems that mimic
half a membrane [17], we intended to focus our study on the ectodo-
main of the protein. Three samples of cell extracts containing differ-
ent amounts of syndecan-4, one of which is tumorigenic cell lines,
were used. Also we investigated processes of molecular recognizing
in which it is believed syndecan-4 to be involved. For that, we have
employed biological molecules for which interactions with
syndecan-4 are reported, such as, heparin, and epidermal growth fac-
tor (EGF). Speciﬁc regions of biomolecule's interaction on syndecan-4
moieties were inferred from data obtained from surface chemis-
try (tensiometry and polarization modulation infrared reﬂection–
absorption spectroscopy: PM-IRRAS).
2. Materials and methods
2.1. Heparan sulfate and growth factor
Heparan sulfate from bovine pancreas was a gift from the late Dr. P
Bianchini (Opocrin Research Laboratories, Modena, Italy). Epidermal
growth factor (EGF) was acquired from Sigma-Aldrich.2.2. Cell culture
Endothelial cell line derived from rabbit aorta (EC) [36], EC trans-
fected with EJ-ras oncogene (EJ-ras EC) [37] and EC transfected with
plasmid vector for the expression of RNA interference to syndecan-4
(shRNA-Syn4-EC) (unpublished data) were grown in F-12 medium
(Gibco BRL, Grand Island, USA) supplemented with 10% fetal calf
serum (FCS) (Cultilab, Campinas, SP, Brazil) in the presence of peni-
cillin (100 U/mL) and streptomycin (100 μg/mL). They were grown
at 37 °C in a humidiﬁed, 2.5% CO2 atmosphere and sub-cultured
every week with Pancreatin (Sigma-Aldrich, St. Louis, MO, USA).
2.3. Extraction of syndecan-4
Proteoglycans synthesized by the cells were metabolically labeled
with [35S]-sulfate (150 μCi/mL) in F-12 medium for 18 h at 37 °C in
2.5% CO2 atmosphere. Afterward, the culture medium was removed
and the cells washed twice with F-12 medium and scrapped from
the dish with 3.5 M urea in 25 mM Tris–HCl pH 7.8. Syndecan-4 was
identiﬁed and quantiﬁed by agarose gel electrophoresis, as previously
described in [37,38]. Syndecan-4 was located by exposure of the gels
(after ﬁxation, drying and staining) to Kodak X-ray ﬁlm (SB-5) for
3–15 days. The samples of lipids and commercial proteins used in
this work had purity above 99%. Extract of syndecans was not further
puriﬁed in order to not interfere with the synergistic process involved
in their interaction with membranes. Also, we intend to avoid rele-
vant alterations to the secondary and tertiary structures of the protein
owing to the further process of puriﬁcation.
2.4. Langmuir monolayers
Langmuir monolayers were obtained spreading a chloroform
(Sigma) solution of dipalmitoylphosphatidylcholine (DPPC), pur-
chased from Sigma-Aldrich, on the surface of a buffer aqueous solution
(Tris 25 mmol/L, urea 3.5 M; pH correct to 7.8 with diluted HCl; all
from Sigma-Aldrich). The lipid concentration was 0.7 mmol/L, and
the spread volume as 50 μL, rendering 2.1×1016 molecules at the sur-
face. Water employedwas previously puriﬁed by aMilliQ-Plus System
(resistivity 18.2 MΩ cm, pH 5.5). Surface pressure-area (π-A) iso-
therms were obtained in a mini-KSV Langmuir trough, equipped
with a surface pressure sensor (Wilhelmy method), with interface
compression rate at 5 Å2 molecule−1 min−1. After 20 min. allowed
for chloroform evaporation, the DPPC monolayer was compressed
until the surface pressure of 30 mN/m, and then the proteins and sac-
charides studied in this work were injected in the aqueous subphase
behind the trough barriers to avoid monolayer disturbance, and
allowed for stabilization for 1 h. The stabilization has been checked
with PM-IRRAS spectroscopy until no signal variation of signal is
detected. Also, the surface pressure was kept constant at 30 mN/m
by moving the barriers, and the stabilization of the monolayer was
also checked until no movement of the barriers was more needed.
Consequently, these experiments were carried out at constant surface
pressure regime. PM-IRRASmeasurementswere takenwith a KSV PMI
550 instrument (KSV Instrument Ltd, Helsinki, Finland) at a ﬁxed inci-
dence angle of 75°. To evaluate as syndecan shifts the monolayer to
large areas and also to investigate the mixed monolayer in all 2-D
states reachable by the monolayer, from expanded phases to the col-
lapse, surface pressure-area isotherms were obtained. For that, the
monolayer was then expanded to the maximum area allowed for the
Langmuir trough and then compressed to collapse. All the experi-
ments were carried out at a controlled room temperature (25 °C).
3. Results and discussion
Fig. 1 shows the infrared absorption bands for mixed DPPC-
syndecan-4 monolayers obtained at 30 mN/m. To minimize the
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1213L. Caseli et al. / Biochimica et Biophysica Acta 1818 (2012) 1211–1217inﬂuence of the bands for DPPC that ﬁts in the range portrayed in
these spectra, the spectrum for pure DPPC, which presents two
main bands at 1730 cm−1 (C_O stretch in ethers) and 1240 cm−1
(P_O stretch in phosphate), was taken as subtracted background.
With introduction of EC extract in the monolayer, the bands related
to amide in polypeptides are presented. The one at 1522 cm−1 is re-
lated to amide II (H\N\C bends) and the ones at 1670, 1647 and
1614 cm−1 are related to amide I (C_O stretches), in β-turns, unor-
dered and β-sheet structures respectively. These results therefore re-
ﬂect the secondary structure of the protein inserted in the monolayer.
As vibration transition for H\O\H bend for water absorbs in the
range of 1650–1700 cm−1 [39], the group of bands for amide I turns
negative because of the difference of the reﬂectivity between the
air–water interface covered with DPPC and with DPPC-syndecan-4,
reﬂecting therefore loss of interfacial water molecules. This is an in-
dicative that the heparan sulfate chains attached to syndecam-4 re-
place some interfacial water molecules. This result is another
evidence therefore that syndecan-4 was incorporated at the interface.
The bands in 1245 and in 1267 cm−1 are related to S_O stretches in
alkyl sulfate ethers and salts, groups present in the heparan sulfate
chains. These bands probably overlap the ones for phosphate groups
in DPPC. Hence it is reasonable to assume that these bands may be at-
tributed to sulfate and not for DPPC because: i) spectrum for pure
DPPC monolayer is subtracted in the normalized spectra; ii) the
bands for phosphate that appeared for pure DPPC monolayer is
about 10-fold smaller than the ones obtained with syndecan-4; and
iii) it is reported in the literature that the band for asymmetric P_O
stretching of PO2 (centered at 1269 cm−1) is overlapped by asym-
metric stretching bands of S_O, which is centered at 1239 cm−1 [34].
Interestingly, the position of the amide I bands reﬂects the second-
ary structure of the proteins inserted in the monolayer. It has been1800 1700 1600 1300 1200 1100 1000
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Fig. 1. PM-IRRAS spectra for DPPC monolayers at 30 mN/m with EC (A) and EJ-ras EC
(B), as subphase, both at concentrations of 25 μg/L. The spectra were normalized
with pure DPPC monolayer taken as background.
Fig. 2. Surface pressure-area isotherms (A) and In-plane elasticity-area isotherms
(B) for DPPC monolayers on aqueous subphase of samples with probable expression
of syndecan-4 (25 μg/L).The kind of syndecan extract is indicated in the insets. Superior
inset in Panel A shows the absence of hysteresis through compression–decompression
curves.reported that for syndecan-4 a typical β-sheet protein containing
only minor amounts of α-helix [40], with 45% of amino acids to reside
in β-sheets and less than 5% in α-helices, and the remaining amino
acids being part of loops. As a strong negative band has appeared be-
cause of the water molecule replacement by syndecan-4, it is difﬁcult
to establish a relationship between the secondary structure compo-
nents. However, we observe that the protein at the monolayer is
structured mainly in β-structures, as reported in the literature [40].
For EJ-ras EC, the bands shown in Fig. 2B reveal α-helix structures
(shoulder at 1653 cm−1), and also the presence of sulfates (strong
band at 1267 cm−1). The band at 1165 cm−1 that appeared for EJ-
ras EC can be attributed to C\O\C in glycosyl groups. For EC, the
bands were too small, being confounded with noises in the spectra.
This makes therefore more evident that the substance that is being in-
corporated in the monolayer is a heparan sulfate proteoglycan–syn-
decan-4. The higher amount incorporated when 4H was used as
subphase conﬁrms the fact that this cellular line expresses higher
amounts of syndecan-4.
The infrared spectrum for DPPC on a shRNA-Syn4-EC subphase is
practically coincident with the ﬁngerprint for pure DPPC. No signiﬁ-
cant bands for amide, glycosyl or sulfate groups are present, revealing
neglecting adsorption of glycoproteins at the DPPC monolayer. With
the normalization employed, we have obtained a straight line spec-
trum, and for the sake of clarity, it is not shown.
As the extract contained other biological molecules that are im-
portant to maintain the structure and function of syndecan, we
inserted a growth factor and heparin in the lipid monolayers to iden-
tity whether, in fact, the effects observed in the surface pressure-area
40 50 60 70 80 90 100 110 120 130
0
10
20
30
40
50
60
70
80
Su
rfa
ce
 P
re
ss
ur
e 
(m
N/
m)
DPPC molecular area (Å2)
EC
EC + EGF2
Fig. 4. Surface pressure-area isotherms for DPPC monolayers with EGF as subphase
(25 μg/L) with or without EC (25 μg/L), as indicated in the inset.
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groups from syndecan.
Fig. 2 shows the incorporation of extracts containing syndecan-4
in DPPC monolayers. This could be done by decompressing the mono-
layer from 30 mN/m to its maximum area and compressing it to col-
lapse following the variation of surface pressure. This is important
in order to better infer the behavior of syndecan in all possible surface
densities, considering the heterogeneity of a surface membrane in
terms of lateral pressure, ﬂuidity, surface molecular packing, visco-
elasticity and compressibility parameters. Also, it is reported that syn-
decans are encountered in several kinds of biointerfaces, including
those that bear a great range of surface tensions, such as pulmonary
alveolar cells [41,42]. For all extracts, a range of extract concentra-
tions varying from 5 to 50 μg/L has been employed. In concentrations
higher than 25 μg/L there were no more changes in the isotherms,
representing that this concentration has a limit value. For this reason,
for the sake of comparison, we show the curves reporting the effect of
the extracts in the monolayer aqueous subphase always with the
same concentration (25 μg/L). Clearly, we observe a more pro-
nounced effect in the isotherms caused by EC and EJ-ras EC. The
curves are shifted to larger DPPC molecular areas, proving the incor-
poration of some material from these extracts at the air–water inter-
face. However, for shRNA-Syn4-EC, there is no signiﬁcant change in
the isotherms when compared to that for pure DPPC monolayer,
where only an expansion of 1–3 Å2/molecule at surface pressures
around 10–15 mN/m, and a slight condensation of the monolayer at
higher surface pressures were being observed. If we consider the sur-
face pressure correspondent to that for a cell membrane [43], i.e.
30 mN/m, the isotherm shifted from 50 to 60 Å2/molecule of DPPC
for EC. This area corresponds not only to the area of the fraction of
glycoprotein incorporated into the monolayer, but also is the effect
from the lateral repulsion between the lipid alkyl chains and proteo-
glycan moieties. For the EJ-ras EC extract, the shift to larger areas is
even higher, going from 50 to 65 Å2/molecule of DPPC. It is believed
that EJ-ras EC overexpresses syndecan-4 [37], while shRNA-Syn4-EC
is silent, expressing no signiﬁcant amounts of syndecan-4 [unpub-
lished data]. These facts are a ﬁrst indication that the expansion ob-
served in the isotherms is owing to the heparan sulfate
proteoglycan incorporated in the DPPC monolayer. Also, the surface
elasticity changed considerably. The parameter that measures elastic-
ity in Langmuir monolayers is known as surface compressional mod-
ulus, or in-plane elasticity, deﬁned as −1/A (dπ/dA)T; [44], being A,
the molecular area, and T the absolute temperature. This parameter
drops from 280 mN/m for pure DPPC to 145 mN/m for DPPC–EJ-ras
EC at a molecular area of 58 Å2 as shown in Fig. 1B. The decrease is re-
lated to the effect of the ﬂuidization of the monolayer caused by the
molecules from the extract. For shRNA-Syn4-EC, however, we ob-
serve a more signiﬁcant decrease of the surface elasticity, which20 40 60 80 100 120
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Fig. 3. Surface pressure-area isotherms for DPPC monolayer with EGF as aqueous sub-
phase (25 μg/L).goes to 78 mN/m, being in the range of the so-called liquid-ordered
phases [44]. It is therefore reasonable to assume that the greater the
amount of syndecan-4 adsorbed in the lipid monolayer, the more pro-
nounced the effect in the packing properties of the Langmuir ﬁlm.
Compression–decompression curves for the hybrid monolayer
(see as example the curve in the inset of Fig. 2A) revealed that
there are very slight displacements of the isotherms to lower molec-
ular areas with successive cycles. Consequently, there is no hysteresis
when comparing curves of compression and decompression, proving
the thermodynamic stability of the monolayer.
As epidermal growth factors (EGF) are heparin-binding proteins
that interact with cell surface associated with heparan sulfate proteo-
glycans, we have inserted EGF in the aqueous subphases of the mono-
layers produced in this work to investigate the process of molecular
recognizing involving syndecan-EGF by means of tensiometry and in-
frared spectroscopy of hybrid syndecan–DPPC monolayers.
Firstly, we introduce EGF as subphase of pure DPPC monolayers to
analyze the surface activity of this protein. In Fig. 3, we observe that
EGF does not change signiﬁcantly the isotherm for DPPC. Also the
PM-IRRAS spectra (not shown) presented a straight line in the region
of amide and sulfate groups (1700–1100 cm−1), proving that EGF has
a negligible surface activity to DPPC monolayers.
Fig. 4 shows that the growth factor, despite not inﬂuencing the
isotherm for pure DPPC, decreases the surface pressure for the
phase transition from liquid-expanded to liquid-condensed for EC–
DPPC monolayers and shifts the isotherms to lower areas. This indi-
cates that EGF does not penetrate in the hybrid proteoglycan-lipid
monolayer. It is likely that the EGF interacts with the heparan sulfate
chains of syndecan-4, implying that the heparan sulfate effects on cell
growth are likely to be mediated by growth factors [8,45–49]. These
chains may be localized in the subsurface just below the lipid–protein
monolayer as portrayed in Fig. 5. The EGF–heparan sulfate interaction
may relax the lipid–syndecan interaction owing to the polypeptide
moiety buried into the DPPC monolayer. This molecular relaxation
must cause the condensation of the monolayer, originating the shift
to lower areas observed in the surface pressure-area isotherm. This
relaxation is followed by an increase in the monolayer compressibili-
ty, which means that dπ/dA becomes higher for the monolayer with
EGF when compared to the monolayer without EGF at surface pres-
sures higher than 10 mN/m.
The PM-IRRAS spectra shown in Fig. 6 show slightly changes in the
band positions for amide I, showing that the polypeptide moiety is lit-
tle affected with EGF binding. Only a shift in the unordered band that
goes from 1647 to 1644 cm−1, as a probable indication of the relaxa-
tion between DPPC and the syndecan-4 moiety (transmembrane do-
main) buried in the lipid monolayer, as suggested in the model
above. However, the region for sulfate and sugar changed drastically
when compared to the spectra of Fig. 2. The bands for sulfate in
Fig. 5.Model for interaction of EGF with syndecan-4 in Langmuir monolayer. EGF binds to sulfate group in the heparan chain, which causes distortion in the polypeptide chain. The
fraction of the polypeptide chain buried into the lipid monolayer relaxes the interface, condensing the lipid monolayer.
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at low surface pressures. With compression, this band goes to
1220 cm−1, becoming positive. With compression, the relative inten-
sity (− I1/I2) between the bands in 1264 cm−1 (I1) and in 1220 cm−1
(I2) decreases from 2.5 to 0.7, indicating that the EGF–sulfate interac-
tion depends on the monolayer surface density. These results thus
corroborate the fact that EGF interacts mainly with the sulfate group
of the heparin sulfate chains of syndecan-4.
Figs. 7 and 8 conﬁrm the hypothesis that EGF does not penetrate
into the lipid monolayer, but should interact with the lateral chains
of syndecan-4. This conclusion is gotten since there is an evident
shift to lower molecular areas with EFG introduction, which reﬂects
the over-expression of the proteoglycan in the EJ-ras EC extract.
Also, the in-plane elasticity changed considerably, as shown in the
inset for Fig. 7. The PM-IRRAS spectra show that the amide region
is little affected. Now the unordered structure is better deﬁned in
1650 cm−1 as the only consequence of EGF interaction, maybe
reﬂecting the DPPC–polypeptide interaction relaxation caused indi-
rectly by EFG binding in the extracellular domain. Again, the sulfate
region is strongly affected showing the strong negative band at
1267 cm−1. Additionally, a band at 1143 cm−1 is observed, which
is attributed to sugar vibration transitions from the heparin sulfate
chain.
It is important to call attention to the fact that the same experi-
ments were essayed for shRNA-Syn4-EC and EGF, but no signiﬁcant1800 1600 1400 1200 1000
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Fig. 6. PM-IRRAS spectra for DPPC monolayers at 30 mN/m on mixed EGF–EC (both at
25 μg/L) as subphase. Offset for clarity.change was observed in the surface pressure-area isotherms and in
the infrared spectra (not shown) other than those for shRNA-Syn4-
EC/DPPC, corroborating the fact that the small amounts of the
syndecan-4 in this extract will not affect the surface properties of
the monolayer. Also, these results indicate that indeed the main mol-
ecule that causes surface activity in the monolayer is syndecam-4.
Finally, we have employed, instead of syndecan-4, heparin, a
highly-sulfated glycoaminoglycan, whose chemical structure is quite
similar to that for the heparam-sulfate chain linked to syndecam-4
(Figs. 9 and 10). Since it does not present hydrophobic domains as
proteoglycans, the expansion of DPPC monolayer is less signiﬁcant
when compared to syndecans (EC and EJ-ras EC). However, as the
EGF insertion in the aqueous suphase shifted the isotherms to lower
molecular areas, it is likely that the interaction of heparin with EGF
causes the removal of heparin from interface solubilizing the complex
EGF-heparin to the subphase. Also, it is important to emphasize that
heparin was not employed in this study to investigate syndecan–hep-
arin interactions, but to comprehend, at the molecular level, the
chemical groups involved in growth factor/sulfate glycoaminoglycan
interactions by taking advantage of the chemical similarity between
syndecan and heparin.40 60 80 100 120
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Fig. 7. Surface pressure-area isotherms for DPPC monolayers with growth factor as sub-
phase without or with EJ-ras EC (25 μg/L) as indicated in the inset. Inset shows the In-
Plane Elasticity-Area isotherms.
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Fig. 8. PM-IRRAS spectra for DPPC monolayers at 30 mN/m with EJ-ras EC and growth
factor as subphase.
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Fig. 10. PM-IRRAS spectra for DPPC monolayers at 30 mN/m with EGF (25 μg/mL) and
heparin (25 μg/mL) as subphase. Offset for clarity.
1216 L. Caseli et al. / Biochimica et Biophysica Acta 1818 (2012) 1211–1217PM-IRRAS spectra for heparin-DPPC show the band for S_O
stretch at 1276 cm−1, but no band for amide was observed. That is
expected because polypeptide groups are absent. However a strong
negative band is observed in 1727 cm−1, related to C_O in DPPC,
that can be attributed to the interaction of this group with heparin,
which is reasonable because the polar afﬁnity between these groups.
The band in 1520 cm−1 is owing to the bending of H\O\H in water
molecules that were replaced by heparin molecules in the subsurface
for the DPPC monolayer. The spectra, taken when EFG was intro-
duced, changes completely, as a proof for the remarkable interaction
with heparin.
4. Conclusions
This paper shows that syndecan-4 is able to be incorporated in
simpliﬁed model for the cell membrane outer layer at the air–water
interface. Tumorigenic cells that express syndecan-4 expand the
monolayer to higher lipid areas while silent cells for syndecan-4 do
not. Growth factor presents no signiﬁcant effect on the lipid monolay-
er without syndecan-4, but with the proteoglycan inserted in the lipid
monolayer, it interacts somehow causing ﬁlm condensation. This ef-
fect was explained by a model in which the growth factor links to
the sulfate groups present in the glycan moiety of syndecan-4,
which induces to chain of events that affects the polypeptide moiety
buried in the lipid monolayer, causing its relaxation and resultant
condensation. In conclusion, we believe that these results may have
an important impact on the comprehension about the interaction of
heparan sulfate proteoglycan involved in biochemical process at the
level of cell membrane surfaces.40 50 60 70 80 90 100 110 120
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